35 studies found for:    " March 06, 2013":" April 05, 2013"[FIRST-RECEIVED-DATE]AND HIV[CONDITION]
Show Display Options
Rank Status Study
21 Completed Safety & Immunogenicity of Immunisations With EN41-UGR7C HIV Vaccine
Condition: - HIV
Interventions: Biological: EN41-UGR7C HIV vaccine;   Biological: NaCl
22 Unknown  Impact on T Cell Immune Activation and Inflammation of Triptolide Woldifii in HIV-infected Immunological Non-responders
Condition: HIV
Interventions: Drug: Triptolide;   Drug: cART;   Drug: placebo
23 Completed Study of Dolutegravir (DTG) on PK of Cenicriviroc (CVC), and CVC on PK of DTG & on a Single Dose of Midazolam
Condition: HIV-infection/AIDS
Interventions: Drug: Cenicriviroc;   Drug: Dolutegravir;   Drug: Midazolam
24 Completed THISTLE - The HIV-HCV Silibinin Trial
Conditions: HIV;   Hepatitis C
Intervention: Drug: Intravenous Silibinin (iSIL)
25 Recruiting Enhancing Quality Interventions Promoting Healthy Sexuality
Conditions: Pregnancy in Adolescence;   HIV
Interventions: Behavioral: Making Proud Choices;   Behavioral: Making Proud Choices AND Getting To Outcomes
26 Recruiting Risky Decision Making in Methamphetamine Users: The Role of Opioid Blockade
Conditions: Methamphetamine Abuse;   HIV
Interventions: Drug: Extended release naltrexone;   Drug: Placebo
27 Active, not recruiting A Prospective, With One Site, Open-label Not Controled Trial, for the Observation of Treatment With CIDOFOVIR 1%, 3 Nights Per Week, During 4 Weeks, of Anal Intraepithelial Neoplasia, High Level, in HIV+ Patients
Condition: HIV
Intervention: Drug: Cidofovir 1% cream's basis, 2gr, three times per week, during 4 weeks.
28 Recruiting Fluoride Metabolism, Bone Remodelling and Mineral Density in HIV Patients Treated With Tenofovir +/- Emtricitabine
Condition: HIV+
Intervention:
29 Recruiting Cabozantinib-S-Malate in Treating Patients With Advanced Solid Tumors and Human Immunodeficiency Virus
Conditions: Adult Solid Neoplasm;   HIV Infection
Interventions: Drug: Cabozantinib S-malate;   Other: Pharmacological Study;   Other: Laboratory Biomarker Analysis
30 Recruiting Influence of Reproductive Cycle and Menopause on HIV-1 Infection and TFV Gel Activity
Condition: HIV Prevention
Interventions: Drug: TFV 1% gel;   Drug: Estradiol vaginal cream
31 Active, not recruiting In Vivo Drug Interaction Pharmacokinetic Study of Tenofovir 1% Gel and Three Commonly Used Vaginal Products
Condition: HIV Prevention
Interventions: Drug: Tenofovir 1% gel;   Drug: Vaginal product
32 Completed A Phase 4 Cross-Sectional Study of Bone Mineral Density in HIV-1 Infected Subjects
Condition: HIV Infections
Intervention:
33 Recruiting Evaluating the Safety and Pharmacokinetics of Raltegravir in Infants
Condition: HIV Infections
Intervention: Drug: Raltegravir
34 Completed Comparison of the QT/QTc Interval Between an Outpatient HIV-Infected Population on Antiretroviral Therapy and Two Large HIV-Negative Cohorts
Condition: QT and Corrected QT Intervals Prolongation in HIV Positive Subjects Treated With an Antiretroviral Regimen
Intervention:
35 Recruiting Clinical Monitoring to Facilitate Continuous Care for Substance Abusing Clients
Conditions: Substance-Related Disorders;   Mental Disorders
Intervention: Behavioral: RecoveryTrack - Extended Care (RT-E)

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-35) Next Page   
Indicates status has not been verified in more than two years